WallStreetZenWallStreetZen

NASDAQ: GCTK
Glucotrack Inc Stock Ownership - Who owns Glucotrack?

Insider buying vs selling

Have Glucotrack Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when GCTK insiders and whales buy or sell their stock.

GCTK Shareholders

What type of owners hold Glucotrack Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Sabby Management LLC1.60%428,908$386.45kInstitution
Alerus Financial Na0.26%69,279$62.42kInstitution
Citadel Advisors LLC0.15%39,183$35.30kInstitution
Boston Financial Mangement LLC0.10%26,372$23.76kInstitution
Accurate Wealth Management LLC0.08%22,098$19.91kInstitution
Virtu Financial LLC0.07%18,913$17.04kInstitution
Allen Danzig0.06%15,048$13.56kInsider
Two Sigma Securities LLC0.05%13,322$12.00kInstitution
Ubs Group Ag0.02%4,800$4.32kInstitution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

GCTK vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GCTK2.33%0.06%
EKSO4.27%95.73%Net Selling
NEPH5.62%94.38%Net BuyingNet Buying
MHUA1.22%0.00%
NXGL2.02%31.25%Net BuyingNet Buying

Glucotrack Stock Ownership FAQ

Who owns Glucotrack?

Glucotrack (NASDAQ: GCTK) is owned by 2.33% institutional shareholders, 0.06% Glucotrack insiders, and 97.62% retail investors. Allen Danzig is the largest individual Glucotrack shareholder, owning 15,048.00 shares representing 0.06% of the company. Allen Danzig's Glucotrack shares are currently valued at $11.44k.

If you're new to stock investing, here's how to buy Glucotrack stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.